Natera, Inc. (NTRA): Revenue
$2.31B
Year ended 2025-12-31
$2.71B
Trailing 12 months to 2026-06-30
+41.1%
3-year compound annual growth
+42.6%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.31B | +35.9% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $1.70B | +56.7% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $1.08B | +32.0% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $820.22M | +31.1% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $625.49M | +60.0% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $391.00M | +29.3% | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | $302.33M | +17.3% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $257.65M | +22.9% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $209.62M | -1.4% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $212.51M | n/a | 2019-03-15, From 2016-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Natera, Inc. (NTRA) | 2025-12-31 | $2.31B | +35.9% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.04B | +11.5% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | +1.0% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $982.02M | +32.9% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $812.03M | +97.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $517.14M | +16.0% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $11.04B | +11.8% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $13.95B | +7.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $379.81M | +13.8% |
Compare NTRA, RDNT, FTRE, GH side by side · Screen every company in Services-Medical Laboratories ↗